Inhibition of Cav2.3—alone or in combination with inhibition of L-type and/or T-type voltage-gated Ca2+ channels14,23—could form the basis of a neuroprotective strategy for Parkinson’s disease in the future. The gene discussed is CACNA1E; the disease is Parkinson disease.